Brachytherapy
Volume 8, Issue 3 , Pages 313-317, July 2009

Endoscopic brachytherapy for obstructive colorectal cancer

  • Tiffany Y. Tam

      Affiliations

    • Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, 699 Concession Street, Hamilton, ON L8V 5C2, Canada. Tel.: +1-905-387-9495; fax: +1-905-575-6326.
  • ,
  • Som Mukherjee

      Affiliations

    • Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Tom Farrell

      Affiliations

    • Department of Medical Physics, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • David Morgan

      Affiliations

    • Department of Medicine, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Ranjan Sur

      Affiliations

    • Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    • Department of Medicine, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada

published online 11 February 2009.

Abstract 

Purpose

Palliation of obstructive colon cancer is often challenging. Treatment options include Yttrium aluminum garnet (YAG) laser, stent placement, and surgical intervention. High-dose-rate intraluminal brachytherapy (HDRILBT) has been used to relieve obstructive symptoms due to rectal, bronchial, and esophageal cancers. In this case report, we document the combined use of YAG laser and HDRILBT for the palliation of obstructive colon cancer at the hepatic flexure, not previously reported in the literature.

Methods and Materials

The patient in this case report had a large colonic tumor at the hepatic flexure causing near complete obstruction. Stent insertion and surgery were not feasible. YAG laser was used once and 11 days later, two fractions of HDRILBT were given 1 week apart. Under endoscopic vision and fluoroscopic guidance, a 150-cm Teflon catheter was passed through the lumen of the partially obstructed bowel for purposes of HDRILBT. A total dose of 10Gy was delivered at 1cm from the center of the source axis using a high-dose-rate afterloader.

Results

After treatment with the first fraction of HDRILBT, the tumor size decreased and the colonic lumen was significantly more patent. The patient's symptoms were significantly relieved after two fractions. Her weight increased and she was medically fit enough to undergo further chemotherapy. Further HDRILBT was not indicated. The calculated biological effective dose for the total HDRILBT treatments was well below the dose tolerances for acute effects for normal colonic tissue.

Conclusion

HDRILBT should be considered as a possible treatment option for obstructive colon cancers when stent placement or surgery is not possible.

Keywords: High-dose-rate brachytherapy, Colon cancer, Obstruction, Laser

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1538-4721(08)00702-2

doi:10.1016/j.brachy.2008.12.003

Brachytherapy
Volume 8, Issue 3 , Pages 313-317, July 2009